JP7692359B2 - 新規な架橋アルギン酸構造体 - Google Patents

新規な架橋アルギン酸構造体 Download PDF

Info

Publication number
JP7692359B2
JP7692359B2 JP2021548963A JP2021548963A JP7692359B2 JP 7692359 B2 JP7692359 B2 JP 7692359B2 JP 2021548963 A JP2021548963 A JP 2021548963A JP 2021548963 A JP2021548963 A JP 2021548963A JP 7692359 B2 JP7692359 B2 JP 7692359B2
Authority
JP
Japan
Prior art keywords
group
formula
alginic acid
alkyl group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021548963A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021060336A1 (https=
JPWO2021060336A5 (https=
Inventor
正司 古迫
智裕 鳴海
勉 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of JPWO2021060336A1 publication Critical patent/JPWO2021060336A1/ja
Publication of JPWO2021060336A5 publication Critical patent/JPWO2021060336A5/ja
Priority to JP2025091584A priority Critical patent/JP2025131662A/ja
Application granted granted Critical
Publication of JP7692359B2 publication Critical patent/JP7692359B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/04—Alginic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Composite Materials (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
JP2021548963A 2019-09-25 2020-09-24 新規な架橋アルギン酸構造体 Active JP7692359B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025091584A JP2025131662A (ja) 2019-09-25 2025-06-02 新規な架橋アルギン酸構造体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019173882 2019-09-25
JP2019173882 2019-09-25
PCT/JP2020/035932 WO2021060336A1 (ja) 2019-09-25 2020-09-24 新規な架橋アルギン酸構造体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025091584A Division JP2025131662A (ja) 2019-09-25 2025-06-02 新規な架橋アルギン酸構造体

Publications (3)

Publication Number Publication Date
JPWO2021060336A1 JPWO2021060336A1 (https=) 2021-04-01
JPWO2021060336A5 JPWO2021060336A5 (https=) 2023-09-20
JP7692359B2 true JP7692359B2 (ja) 2025-06-13

Family

ID=75167007

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021548963A Active JP7692359B2 (ja) 2019-09-25 2020-09-24 新規な架橋アルギン酸構造体
JP2025091584A Pending JP2025131662A (ja) 2019-09-25 2025-06-02 新規な架橋アルギン酸構造体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025091584A Pending JP2025131662A (ja) 2019-09-25 2025-06-02 新規な架橋アルギン酸構造体

Country Status (5)

Country Link
US (1) US12479933B2 (https=)
EP (1) EP4035735A4 (https=)
JP (2) JP7692359B2 (https=)
CN (2) CN120463977A (https=)
WO (1) WO2021060336A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4663627A1 (en) * 2023-02-06 2025-12-17 NOF Corporation Amine hydrochloride having maleimide group, and method for producing same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010512433A (ja) 2006-12-11 2010-04-22 常州百瑞吉生物医▲薬▼有限公司 チオール修飾高分子誘導体およびその架橋材料
WO2010087912A1 (en) 2009-01-30 2010-08-05 University Of Utah Research Foundation Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
WO2014028209A1 (en) 2012-08-14 2014-02-20 The Trustees Of The University Of Pennsylvania Stabilizing shear-thinning hydrogels
WO2014058359A1 (en) 2012-10-09 2014-04-17 Yuji Teramura Method of coating and encapsulation of cells and cell aggregates with thick and stable polymer membrane
WO2015154078A1 (en) 2014-04-04 2015-10-08 President And Fellows Of Harvard College Click-crosslinked hydrogels and methods of use
WO2019189330A1 (ja) 2018-03-28 2019-10-03 持田製薬株式会社 新規反応性アルギン酸誘導体

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
WO1993013136A1 (en) 1991-12-20 1993-07-08 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
JPH08269102A (ja) 1995-03-30 1996-10-15 Shiseido Co Ltd エンドトキシンフリーのβ１，３−グルカン及びその製造法並びに医療用ゲル素材
JPH09324001A (ja) 1996-04-02 1997-12-16 Kyowa Hakko Kogyo Co Ltd ヒアルロン酸ナトリウムの精製法
EP1135418A1 (en) 1998-11-13 2001-09-26 CP Kelco U.S., Inc. Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
ATE419528T1 (de) 1999-04-28 2009-01-15 Eidgenoess Tech Hochschule Polyionische beschichtungen für analytische und sensor-vorrichtungen
AU2003299509A1 (en) 2002-06-21 2004-05-13 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
WO2004099259A1 (ja) 2003-05-09 2004-11-18 Toho Chemical Industry Co., Ltd. カチオン変性アルギン酸誘導体及び該物質を含む化粧料組成物
EP1624935B1 (en) 2003-05-15 2016-09-28 The University of Utah Research Foundation Anti-adhesion composites and methods os use thereof
US7008476B2 (en) * 2003-06-11 2006-03-07 Az Electronic Materials Usa Corp. Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof
JP2005036036A (ja) 2003-07-16 2005-02-10 Tanabe Seiyaku Co Ltd エンドトキシン除去方法
TW200526253A (en) 2003-11-14 2005-08-16 Chugai Pharmaceutical Co Ltd Cross-linked polysaccharide microparticles and process for producing the same
JP2007099902A (ja) 2005-10-04 2007-04-19 Kaneka Corp アルギン酸誘導体、ポリアクリル酸誘導体およびそれらの製造方法
ITMI20061726A1 (it) 2006-09-11 2008-03-12 Fidia Farmaceutici Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
JP2010209130A (ja) 2009-03-06 2010-09-24 Teijin Ltd アルギン酸誘導体およびその製造方法
FR2967678A1 (fr) 2010-11-18 2012-05-25 Centre Nat Rech Scient Derives de polysaccharides comprenant un motif maleimide et reaction de couplage par chimie thio-clic
CN102408496B (zh) * 2011-09-13 2013-02-06 武汉理工大学 一种原位交联海藻酸钠水凝胶及其制备方法
AU2012347926B2 (en) 2011-12-05 2018-03-15 Incept, Llc Medical organogel processes and compositions
KR20150028198A (ko) 2013-09-04 2015-03-13 한양대학교 산학협력단 이온 가교성 알긴산-그래프트화 히알루론산 개질체
US20150064143A1 (en) 2013-09-04 2015-03-05 Industry-University Cooperation Foundation Hanyang University Ionically cross-linkable alginate-grafted hyaluronate compound
EP3125866B1 (en) 2014-04-04 2021-03-03 President and Fellows of Harvard College Refillable drug delivery devices and methods of use thereof
US9623234B2 (en) 2014-11-11 2017-04-18 Medtronic, Inc. Leadless pacing device implantation
CN105770903B (zh) 2014-12-25 2019-01-18 南京理工大学 一种温控药物释放聚合物微球材料的制备方法
JPWO2018151186A1 (ja) 2017-02-16 2019-12-12 味の素株式会社 ポリマービーズ
CN109666121B (zh) 2017-10-17 2023-09-22 厦门逍扬运动科技有限公司 一种杂化动态交联聚合物及其应用
CN109776450B (zh) 2017-11-15 2021-03-19 中山光禾医疗科技有限公司 光偶合协同交联水凝胶材料的制备、原料、产品及应用
WO2019172261A1 (ja) 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010512433A (ja) 2006-12-11 2010-04-22 常州百瑞吉生物医▲薬▼有限公司 チオール修飾高分子誘導体およびその架橋材料
WO2010087912A1 (en) 2009-01-30 2010-08-05 University Of Utah Research Foundation Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
WO2014028209A1 (en) 2012-08-14 2014-02-20 The Trustees Of The University Of Pennsylvania Stabilizing shear-thinning hydrogels
WO2014058359A1 (en) 2012-10-09 2014-04-17 Yuji Teramura Method of coating and encapsulation of cells and cell aggregates with thick and stable polymer membrane
WO2015154078A1 (en) 2014-04-04 2015-10-08 President And Fellows Of Harvard College Click-crosslinked hydrogels and methods of use
WO2019189330A1 (ja) 2018-03-28 2019-10-03 持田製薬株式会社 新規反応性アルギン酸誘導体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Biomacromolecules，2018年，19，3390-3400
KAFEDJIISKI,K. et al.，Evaluation of in vitro enzymatic degradation of various thiomers and cross-linked thiomers，Drug Development and Industrial Pharmacy，2007年，33，199-208
SHTENBERG,Y. et al.，Alginate modified with maleimide-terminated PEG as drug carriers with enhanced mucoadhesion，Carbohydrate Polymers，2017年，175，337-346

Also Published As

Publication number Publication date
JPWO2021060336A1 (https=) 2021-04-01
US12479933B2 (en) 2025-11-25
CN114521199B (zh) 2025-05-30
CN114521199A (zh) 2022-05-20
JP2025131662A (ja) 2025-09-09
EP4035735A1 (en) 2022-08-03
CN120463977A (zh) 2025-08-12
EP4035735A4 (en) 2023-10-18
US20220396643A1 (en) 2022-12-15
WO2021060336A1 (ja) 2021-04-01

Similar Documents

Publication Publication Date Title
US10245351B2 (en) Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
CN111868096B (zh) 反应性海藻酸衍生物
WO1987003891A1 (fr) Polypeptide synthetique biodegradable et son utilisation en therapeutique
JP7346380B2 (ja) 新規光架橋性アルギン酸誘導体
JP7704952B2 (ja) 新規な架橋アルギン酸
KR20090109120A (ko) 셀룰로오스 유도체 및 그 제조 방법
JPWO2007000979A1 (ja) 自己組織化ペプチドおよびそれより得られるゲル
JP2025131662A (ja) 新規な架橋アルギン酸構造体
WO2021125279A1 (ja) 化学架橋アルギン酸ゲルファイバ
WO2022145419A1 (ja) 化学架橋アルギン酸を用いた多層構造体
WO2021060351A1 (ja) ＮＳＡＩＤｓ結合アルギン酸誘導体
JP7851458B2 (ja) 新規な架橋アルギン酸
WO2021060395A1 (ja) 徐放性医薬組成物
WO2024062713A1 (ja) ゲル形成用材料及びゲル組成物
CN119707849A (zh) 含硒化合物、聚合物、可注射含硒水凝胶、其制法及用途
EP4255492A1 (en) Use of synthetic copolypeptide hydrogels as dermal fillers

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230908

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250325

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250513

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250603

R150 Certificate of patent or registration of utility model

Ref document number: 7692359

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150